Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area

European Journal of Endocrinology

Volumn 161, Issue 4, 2009, Pages 599-605

  Ayturk, Semra ^a   Gursoy, Alptekin ^a   Kut, Altug ^a   Anil, Cuneyd ^a   Nar, Asli ^a   Tutuncu, Neslihan Bascil ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE; IODINE; THYROID HORMONE;

ADULT; ARTICLE; ASPIRATION BIOPSY; CARCINOGENESIS; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SMOKING; THYROID CANCER; THYROID FUNCTION; THYROID NODULE; TUMOR VOLUME; ADOLESCENT; AGE; AGED; ANTHROPOMETRY; BLOOD; ENDEMIC DISEASE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; THYROID FUNCTION TEST; THYROID GLAND; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTHROPOMETRY; CASE-CONTROL STUDIES; ENDEMIC DISEASES; FEMALE; HUMANS; IODINE; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES; THYROID NODULE; TURKEY; YOUNG ADULT;

EID: 70349778124     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0410     Document Type: Article

References (44)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37 1595-1607.
2. Kokkoris P & Pi-Sunyer FX. Obesity and endocrine disease. Endocrinology and Metabolism Clinics of North America 2003 32 895-914.
3. Sari R, Balci MK, Altunbas H & Karayalcin U. The effect of body weight and weight loss on thyroid volume and function in obese women. Clinical Endocrinology 2003 59 258-262. (Pubitemid 36918663)
4. Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, Psyrogiannis AI, Kalfarentzos FE & Kyriazopoulou VE. Thyroid function in humans with morbid obesity. Thyroid 2006 16 73-78.
5. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P & Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clinical Endocrinology 2007 67 265-269. (Pubitemid 47076304)
6. Bastemir M, Akin F, Alkis E & Kaptanoglu B. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Medical Weekly 2007 137 431-434. (Pubitemid 47195516)
7. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L & Jørgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism 2005 90 4019-4024. (Pubitemid 41058166)
8. Schäffler A, Binart N, Schölmerich J & Büchler C. Hypothesis paper Brain talks with fat - evidence for a hypothalamic-pituitary- adipose axis? Neuropeptides 2005 39 363-367.
9. Pontikides N & Krassas GE. Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid 2007 17 421-431. (Pubitemid 46878845)
10. Rotondi M, Leporati P, La Manna A, Pirali B, Mondello T, Fonte R, Magri F & Chiovato L. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? European Journal of Endocrinology 2009 160 403-408.
11. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F & Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 2008 18 461-464.
12. Van Keymeulen A, Dumont JE & Roger PP. TSH induces insulin receptors that mediate insulin costimulation of growth in normal human thyroid cells. Biochemical and Biophysical Research Communications 2000 279 202-207.
13. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE & Roger PP. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocrine Reviews 2001 22 631-656. (Pubitemid 32955247)
14. Deleu S, Pirson I, Coulonval K, Drouin A, Taton M, Clermont F, Roger PP, Nakamura T, Dumont JE & Maenhaut C. IGF-1 or insulin, and the TSH cyclic AMP cascade separately control dog and human thyroid cell growth and DNA synthesis, and complement each other in inducing mitogenesis. Molecular and Cellular Endocrinology 1999 149 41-51. (Pubitemid 29236222)
15. Kimura T, Dumont JE, Fusco A & Golstein J. Insulin and TSH promote growth in size of PC Cl3 rat thyroid cells, possibly via a pathway different from DNA synthesis: comparison with FRTL-5 cells. European Journal of Endocrinology 1999 140 94-103. (Pubitemid 29074774)
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497.
17. Erdoǧan G, Erdogan MF, Emral R, Baştemir M, Sav H, Haznedaroǧlu D, Ustündaǧ M, Köse R, Kamel N & Genç Y. Iodine status and goiter prevalence in Turkey before mandatory iodization. Journal of Endocrinological Investigation 2002 25 224-228. (Pubitemid 34295876)
18. Erdoǧan MF, Demir O, Emral R, Kamel AN & Erdoǧan G. More than a decade of iodine prophylaxis is needed to eradicate goiter among school age children in a moderately iodine-deficient region. Thyroid 2009 19 265-268.
19. Brunn J, Block U, Ruf G, Bos I, Kunze WP & Scriba PC. Volumetric analysis of thyroid lobes by real-time ultrasound. Deutsche Medizinische Wochenschrift 1981 106 1338-1340.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (Pubitemid 15018832)
21. Park HT, Cho GJ, Ahn KH, Shin JH, Hong SC, Kim T, Hur JY, Kim YT, Lee KW & Kim SH. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas 2009 62 301-305.
22. De Pergola G, Giorgino F, Benigno R, Guida P & Giorgino R. Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome. Obesity 2008 16 2405-2411.
23. Roos A, Bakker SJ, Links TP, Gans RO &Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 491-496. (Pubitemid 46255285)
24. Bruckert E, Giral P, Chadarevian R & Turpin G. Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients. Journal of Cardiovascular Risk 1999 6 327-331. (Pubitemid 30025629)
25. Lin SY, Wang YY, Liu PH, Lai WA & Sheu WH. Lower serum free thyroxine levels are associated with metabolic syndrome in a Chinese population. Metabolism 2005 54 1524-1528.
26. 4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clinical Endocrinology 2009 70 152-160.
27. Rosenbaum M, Hirsch J, Murphy E & Leibel RL. Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function. American Journal of Clinical Nutrition 2000 71 1421-1432. (Pubitemid 30395887)
28. Zimmermann-Belsing T, Brabant G, Holst JJ & Feldt-Rasmussen U. Circulating leptin and thyroid dysfunction. European Journal of Endocrinology 2003 149 257-271.
29. Mantzoros CS & Moschos SJ. Leptin: in search of role(s) in human physiology and pathophysiology. Clinical Endocrinology 1998 49 551-567.
30. Lewandowski K, Randeva HS, O'Callaghan CJ, Horn R, Medley GF, Hillhouse EW, Brabant G & O'Hare P. Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin. Clinical Endocrinology 2001 54 533-539. (Pubitemid 34204190)
31. Menendez C, Baldelli R, Camiña JP, Escudero B, Peino R, Dieguez C & Casanueva FF. TSH stimulates leptin secretion by a direct effect on adipocytes. Journal of Endocrinology 2003 176 7-12. (Pubitemid 36163561)
32. Sorisky A, Bell A & Gagnon A. TSH receptor in adipose cells. Hormone and Metabolic Research 2000 32 468-474.
33. Valyasevi RW, Harteneck DA, Dutton CM & Bahn RS. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. Journal of Clinical Endocrinology and Metabolism 2002 87 2352-2358.
34. Rapoport B, Chazenbalk GD, Jaume JC & McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoanti-bodies. Endocrine Reviews 1998 19 673-716. (Pubitemid 128506520)
35. Mohan S, Baylink DJ & Pettis JL. Insulin-like growth factor (IGF)- binding proteins in serum - do they have additional roles besides modulating the endocrine IGF actions? Journal of Clinical Endocrinology and Metabolism 1996 81 3817-3820.
36. Santisteban P, Acebrón A, Polycarpou-Schwarz M & Di Lauro R. Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Molecular Endocrinology 1992 6 1310-1317.
37. Li X, Lu S, Miyagi E, Katoh R & Kawaoi A. Thyrotropin prevents apoptosis by promoting cell adhesion and cell cycle progression in FRTL-5 cells. Endocrinology 1999 140 5962-5970. (Pubitemid 30645387)
38. Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G & Hansen JM. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. Journal of Clinical Endocrinology and Metabolism 1983 56 260-263. (Pubitemid 13184359)
39. Semiz S, Senol U, Bircan O, Gümüşlü S, Bilmen S & Bircan I. Correlation between age, body size and thyroid volume in an endemic area. Journal of Endocrinological Investigation 2001 24 559-563. (Pubitemid 32951844)
40. Pothiwala P, Jain SK & Yaturu S. Metabolic syndrome and cancer. Metabolic Syndrome and Related Disorders 2009 7 279-288.
41. Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology 2009 20 181-187.
42. Bessesen DH. Update on obesity. Journal of Clinical Endocrinology and Metabolism 2008 93 2027-2034.
43. Grodski S, Brown T, Sidhu S, Gill A, Robinson B, Learoyd D, Sywak M, Reeve T & Delbridge L. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 2008 144 1038-1043.
44. Rezzónico JN, Rezzónico M, Pusiol E, Pitoia F & Niepomniszcze H. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metabolic Syndrome and Related Disorders 2009 7 375-380.